1. Home
  2. NVAX vs PRGO Comparison

NVAX vs PRGO Comparison

Compare NVAX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.05

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$10.83

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
PRGO
Founded
1987
1887
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NVAX
PRGO
Price
$9.05
$10.83
Analyst Decision
Hold
Buy
Analyst Count
9
3
Target Price
$11.33
$19.33
AVG Volume (30 Days)
4.8M
2.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
10.28%
EPS Growth
309.76
N/A
EPS
N/A
N/A
Revenue
$1,123,479,000.00
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.02
P/E Ratio
N/A
N/A
Revenue Growth
64.69
N/A
52 Week Low
$6.20
$9.23
52 Week High
$11.85
$28.44

Technical Indicators

Market Signals
Indicator
NVAX
PRGO
Relative Strength Index (RSI) 45.45 45.27
Support Level $8.89 $10.37
Resistance Level $9.02 $11.85
Average True Range (ATR) 0.68 0.56
MACD -0.21 0.02
Stochastic Oscillator 18.10 28.69

Price Performance

Historical Comparison
NVAX
PRGO

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: